# Typhim Vi

NDC: 49281-790
Generic name: SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN
Labeler / Manufacturer: Sanofi Vaccines US Inc.
Product type: VACCINE
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAMUSCULAR
Marketing started: 19941128

FDA application: BLA103936

## Active ingredients

- SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN: 25 ug/.5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"49281-790"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=49281-790